Ustekinumab during pregnancy and lactation: drug levels in maternal serum, cord blood, breast milk, and infant serum
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ustekinumab during pregnancy and lactation: drug levels in maternal serum, cord blood, breast milk, and infant serum
Authors
Keywords
-
Journal
Journal of Pharmaceutical Health Care and Sciences
Volume 8, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-07-01
DOI
10.1186/s40780-022-00249-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Use of medications during pregnancy and breastfeeding for Crohn’s disease and ulcerative colitis
- (2021) Robyn Laube et al. Expert Opinion On Drug Safety
- Detection of Ustekinumab in Breast Milk of Nursing Mothers With Crohn Disease
- (2021) Ariella Bar-Gil Shitrit et al. INFLAMMATORY BOWEL DISEASES
- Ustekinumab in Paediatric Patients with Moderately to Severely Active Crohn’s Disease: Pharmacokinetics, Safety, and Efficacy Results from UniStar, a Phase 1 Study
- (2021) Joel R Rosh et al. Journal of Crohns & Colitis
- Update on the Management of Inflammatory Bowel Disease during Pregnancy and Breastfeeding
- (2020) Sophie Restellini et al. DIGESTION
- Transfer of monoclonal antibodies into breastmilk in neurologic and non-neurologic diseases
- (2020) Sara C. LaHue et al. Neurology-Neuroimmunology & Neuroinflammation
- Safety of New Biologics (Vedolizumab and Ustekinumab) and Small Molecules (Tofacitinib) During Pregnancy: A Review
- (2020) Javier P. Gisbert et al. DRUGS
- Biologics for Inflammatory Bowel Disease and their Safety in Pregnancy: A Systematic Review and Meta-analysis
- (2020) Ole Haagen Nielsen et al. Clinical Gastroenterology and Hepatology
- Sexual health and fertility for individuals with inflammatory bowel disease
- (2019) Romain Leenhardt et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study
- (2019) Annick Moens et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Exposure Concentrations of Infants Breastfed by Women Receiving Biologic Therapies for Inflammatory Bowel Diseases and Effects of Breastfeeding on Infections and Development
- (2018) Rebecca Matro et al. GASTROENTEROLOGY
- Relationship between the Clinical Course of Ulcerative Colitis during Pregnancy and the Outcomes of Pregnancy: A Retrospective Evaluation
- (2018) Ayumi Ito et al. INTERNAL MEDICINE
- Evidence-based clinical practice guidelines for inflammatory bowel disease
- (2018) Katsuyoshi Matsuoka et al. JOURNAL OF GASTROENTEROLOGY
- From mother to baby: antenatal exposure to monoclonal antibody biologics
- (2018) Anne Pham-Huy et al. Expert Review of Clinical Immunology
- Drug Levels in the Maternal Serum, Cord Blood and Breast Milk of a Ustekinumab-Treated Patient with Crohn’s Disease
- (2018) Entcho Klenske et al. Journal of Crohns & Colitis
- Ustekinumab Drug Levels in Maternal and Cord Blood in a Woman With Crohn’s Disease Treated Until 33 Weeks of Gestation
- (2017) Catherine R Rowan et al. Journal of Crohns & Colitis
- The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO-EpiCom Study of 209 pregnant women
- (2013) N. Pedersen et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Inflammatory bowel disease and pregnancy: Lack of knowledge is associated with negative views
- (2012) Christian P. Selinger et al. Journal of Crohns & Colitis
- Development in the cynomolgus macaque following administration of ustekinumab, a human anti-il-12/23p40 monoclonal antibody, during pregnancy and lactation
- (2010) Pauline L. Martin et al. BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY
- ORIGINAL ARTICLE: Treatment with Adalimumab (Humira®) and Intravenous Immunoglobulin Improves Pregnancy Rates in Women Undergoing IVF*
- (2008) Edward E. Winger et al. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- Fear and fertility in inflammatory bowel disease: A mismatch of perception and reality affects family planning decisions
- (2008) Réme Mountifield et al. INFLAMMATORY BOWEL DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started